Friday, February 22, 2008

3rd Day-1st Talk: “Opportunities in the Design of Second-Generation Protein Therapeutics” by Michael Blaber, PhD

Dr. Michael Blaber received a research grant from the American Heart Association to study “FGF-1 Mutants for Angiogenic Therapy.” Dr. Blaber is a Professor in the Department of Biomedical Sciences in the College of Medicine at Florida State University.

Coming...

No comments: